Cargando…
A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma
BACKGROUND: Glaucoma is a complex, multifactorial disease where apoptosis, microglia activation, and inflammation have been linked to the death of retinal ganglion cells (RGCs) and axon degeneration. We demonstrated previously that FasL-Fas signaling was required for axon degeneration and death of R...
Autores principales: | Krishnan, Anitha, Kocab, Andrew J., Zacks, David N., Marshak-Rothstein, Ann, Gregory-Ksander, Meredith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767653/ https://www.ncbi.nlm.nih.gov/pubmed/31570110 http://dx.doi.org/10.1186/s12974-019-1576-3 |
Ejemplares similares
-
Opposing Roles for Membrane Bound and Soluble Fas Ligand in Glaucoma-Associated Retinal Ganglion Cell Death
por: Gregory, Meredith S., et al.
Publicado: (2011) -
Cell Death in AMD: The Rationale for Targeting Fas
por: Zacks, David N., et al.
Publicado: (2022) -
Mouse model of ocular hypertension with retinal ganglion cell degeneration
por: Mukai, Ryo, et al.
Publicado: (2019) -
Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium
por: Matsumoto, H, et al.
Publicado: (2015) -
Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection
por: Munemasa, Yasunari, et al.
Publicado: (2013)